Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.

Luca QuartuccioGiorgia GregoraciMiriam IsolaSalvatore De Vita

Published in: Geriatrics & gerontology international (2018)

MTX up to 20 mg/day was useful in defined subsets of polymyalgia rheumatica, also in the long term. No significant differences were noticed among the five subgroups. Geriatr Gerontol Int 2018; 18: 1410-1414.

Keyphrases

high dose
giant cell
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
low dose
randomized controlled trial
peritoneal dialysis
prognostic factors
patient reported